Genetic susceptibility to cerebrovascular disease

David Della Morte, Francesca Pacifici, Tatjana Rundek

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose of review Cerebrovascular disease (CeVD) remains a major cause of death and a leading cause of disability worldwide. CeVD is a complex and multifactorial disease caused by the interaction of vascular risk factors, environment, and genetic factors. In the present article, we discussed genetic susceptibility to CeVD, with particular emphasis on genetic studies of the associations between lipid traits and CeVD. Recent findings Several animal and clinical studies clearly defined genetic predisposition to atherosclerosis and CeVD, and particularly to ischemic stroke. Recent evidence has shown that traditional vascular risk factors explain only a small proportion of variance in atherosclerosis, suggesting that additional nontraditional factors and novel genetic determinants impact CeVD. With the help of genome-wide technology, novel genetic variants have been implicated in CeVD and lipid metabolism such as those in protein convertase subtilisin/kexin type 9 (PCSK9) gene in stroke and familial hypercholesterolemia. These studies are important as they contribute to our understanding of the genetic mechanisms underlying CeVD and to developing more effective CeVD prevention strategies. Summary CeVD is a complex and multifactorial disease and genetics likely plays an important role in its pathogenesis. The gene-gene and gene-environment interactions of genes involved in biology of vascular disease, including the lipid metabolism are important factors for individual susceptibility to CeVD. Accounting for individual variation in genes, environment and lifestyle will bring us closer to precision medicine, which is an emerging and recently introduced new approach for disease treatment and prevention in clinical practice.

Original languageEnglish (US)
Pages (from-to)187-195
Number of pages9
JournalCurrent Opinion in Lipidology
Volume27
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Cerebrovascular Disorders
Genetic Predisposition to Disease
Genes
Lipid Metabolism
Atherosclerosis
Stroke
Subtilisin
Gene-Environment Interaction
Precision Medicine
Inborn Genetic Diseases
Hyperlipoproteinemia Type II
Genetic Association Studies
Vascular Diseases
Life Style
Cause of Death

Keywords

  • cerebrovascular disease
  • familial hypercholesterolemia
  • genetics
  • Keywords apolipoproteins
  • lipids
  • monogenic diseases

ASJC Scopus subject areas

  • Cell Biology
  • Genetics
  • Molecular Biology
  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Genetic susceptibility to cerebrovascular disease. / Della Morte, David; Pacifici, Francesca; Rundek, Tatjana.

In: Current Opinion in Lipidology, Vol. 27, No. 2, 01.04.2016, p. 187-195.

Research output: Contribution to journalArticle

@article{991dc83bd41049a8bed145e2775ebf82,
title = "Genetic susceptibility to cerebrovascular disease",
abstract = "Purpose of review Cerebrovascular disease (CeVD) remains a major cause of death and a leading cause of disability worldwide. CeVD is a complex and multifactorial disease caused by the interaction of vascular risk factors, environment, and genetic factors. In the present article, we discussed genetic susceptibility to CeVD, with particular emphasis on genetic studies of the associations between lipid traits and CeVD. Recent findings Several animal and clinical studies clearly defined genetic predisposition to atherosclerosis and CeVD, and particularly to ischemic stroke. Recent evidence has shown that traditional vascular risk factors explain only a small proportion of variance in atherosclerosis, suggesting that additional nontraditional factors and novel genetic determinants impact CeVD. With the help of genome-wide technology, novel genetic variants have been implicated in CeVD and lipid metabolism such as those in protein convertase subtilisin/kexin type 9 (PCSK9) gene in stroke and familial hypercholesterolemia. These studies are important as they contribute to our understanding of the genetic mechanisms underlying CeVD and to developing more effective CeVD prevention strategies. Summary CeVD is a complex and multifactorial disease and genetics likely plays an important role in its pathogenesis. The gene-gene and gene-environment interactions of genes involved in biology of vascular disease, including the lipid metabolism are important factors for individual susceptibility to CeVD. Accounting for individual variation in genes, environment and lifestyle will bring us closer to precision medicine, which is an emerging and recently introduced new approach for disease treatment and prevention in clinical practice.",
keywords = "cerebrovascular disease, familial hypercholesterolemia, genetics, Keywords apolipoproteins, lipids, monogenic diseases",
author = "{Della Morte}, David and Francesca Pacifici and Tatjana Rundek",
year = "2016",
month = "4",
day = "1",
doi = "10.1097/MOL.0000000000000275",
language = "English (US)",
volume = "27",
pages = "187--195",
journal = "Current Opinion in Lipidology",
issn = "0957-9672",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Genetic susceptibility to cerebrovascular disease

AU - Della Morte, David

AU - Pacifici, Francesca

AU - Rundek, Tatjana

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Purpose of review Cerebrovascular disease (CeVD) remains a major cause of death and a leading cause of disability worldwide. CeVD is a complex and multifactorial disease caused by the interaction of vascular risk factors, environment, and genetic factors. In the present article, we discussed genetic susceptibility to CeVD, with particular emphasis on genetic studies of the associations between lipid traits and CeVD. Recent findings Several animal and clinical studies clearly defined genetic predisposition to atherosclerosis and CeVD, and particularly to ischemic stroke. Recent evidence has shown that traditional vascular risk factors explain only a small proportion of variance in atherosclerosis, suggesting that additional nontraditional factors and novel genetic determinants impact CeVD. With the help of genome-wide technology, novel genetic variants have been implicated in CeVD and lipid metabolism such as those in protein convertase subtilisin/kexin type 9 (PCSK9) gene in stroke and familial hypercholesterolemia. These studies are important as they contribute to our understanding of the genetic mechanisms underlying CeVD and to developing more effective CeVD prevention strategies. Summary CeVD is a complex and multifactorial disease and genetics likely plays an important role in its pathogenesis. The gene-gene and gene-environment interactions of genes involved in biology of vascular disease, including the lipid metabolism are important factors for individual susceptibility to CeVD. Accounting for individual variation in genes, environment and lifestyle will bring us closer to precision medicine, which is an emerging and recently introduced new approach for disease treatment and prevention in clinical practice.

AB - Purpose of review Cerebrovascular disease (CeVD) remains a major cause of death and a leading cause of disability worldwide. CeVD is a complex and multifactorial disease caused by the interaction of vascular risk factors, environment, and genetic factors. In the present article, we discussed genetic susceptibility to CeVD, with particular emphasis on genetic studies of the associations between lipid traits and CeVD. Recent findings Several animal and clinical studies clearly defined genetic predisposition to atherosclerosis and CeVD, and particularly to ischemic stroke. Recent evidence has shown that traditional vascular risk factors explain only a small proportion of variance in atherosclerosis, suggesting that additional nontraditional factors and novel genetic determinants impact CeVD. With the help of genome-wide technology, novel genetic variants have been implicated in CeVD and lipid metabolism such as those in protein convertase subtilisin/kexin type 9 (PCSK9) gene in stroke and familial hypercholesterolemia. These studies are important as they contribute to our understanding of the genetic mechanisms underlying CeVD and to developing more effective CeVD prevention strategies. Summary CeVD is a complex and multifactorial disease and genetics likely plays an important role in its pathogenesis. The gene-gene and gene-environment interactions of genes involved in biology of vascular disease, including the lipid metabolism are important factors for individual susceptibility to CeVD. Accounting for individual variation in genes, environment and lifestyle will bring us closer to precision medicine, which is an emerging and recently introduced new approach for disease treatment and prevention in clinical practice.

KW - cerebrovascular disease

KW - familial hypercholesterolemia

KW - genetics

KW - Keywords apolipoproteins

KW - lipids

KW - monogenic diseases

UR - http://www.scopus.com/inward/record.url?scp=84960369032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960369032&partnerID=8YFLogxK

U2 - 10.1097/MOL.0000000000000275

DO - 10.1097/MOL.0000000000000275

M3 - Article

C2 - 26959706

AN - SCOPUS:84960369032

VL - 27

SP - 187

EP - 195

JO - Current Opinion in Lipidology

JF - Current Opinion in Lipidology

SN - 0957-9672

IS - 2

ER -